Despite a 5.7 percent increase in sales to $1,192 million...

Despite a 5.7 percent increase in sales to $1,192 million in the third quarter, Allergan reported a net loss of $670.5 million compared with profits of $239.2 million last year. The overall sales increase was 6.3 percent on a currency-neutral basis. Revenues from eye care pharmaceuticals grew by 6.3 percent ...

Keep reading this article by becoming a member


Enjoy unrestricted access to Eyewear Intelligence

To continue reading this article subscribe now

  • Unlimited access to our highly trusted industry insights and analysis
  • Benchmark yourself against the market and competitors
  • Find inspiration to drive your business forward
  • Stay up to date with new business models and startups

If you aren’t ready to subscribe now, you can REGISTER FOR FREE. Already an Eyewear Intelligence subscriber? Sign in here.